Top-Selling Drugs 2023: Pharma’s $60bn COVID-19 Cliff

Keytruda Towers At Top Of League

 
• By Eleanor Malone
  
Keytruda revenues grew as COVID-19 sales plummeted • Source: Shutterstock
In Vivo Podcast

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.

SpotifyApple PodcastsWebsite

More from Market Intelligence

More from In Vivo